Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis
2015 IPOS APOS World Congress of Psycho-Oncology
Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory
Related Videos
Bradley J. Zebrack, PhD and Ursula Sansom-Daly, PhD
Bradley J. Zebrack, PhD, of the University of Michigan School of Social Work, and Ursula Sansom-Daly, PhD, of the University of New South Wales, talk about providing supportive care services that meet the unique needs of adolescents and young adults with cancer.
Mark Lazenby, PhD, APRN, FAPOS
Mark Lazenby, PhD, APRN, FAPOS, of the Yale School of Nursing, discusses the APOS–ACCC project to screen for psychosocial distress in community cancer centers. These model programs improve patient care and the patient experience.
Jimmie C. Holland, MD, and Tammy A. Schuler, PhD
Jimmie C. Holland, MD, of Memorial Sloan Kettering Cancer Center, and Tammy A. Schuler, PhD, of the Association for Behavioral and Cognitive Therapies, demonstrate a dialogue between a clinician and a recently diagnosed cancer patient whose distress was discovered with the use of the Distress Thermometer.
Jeff Dunn, AO, PhD, GAICD
Jeff Dunn, AO, PhD, GAICD, of the Cancer Council Queensland, discusses reducing the burden of cancer on individuals and communities.
Robert T. Croyle, PhD
Robert T. Croyle, PhD, of the National Cancer Institute, discusses the research program on the variation in the quality of cancer care, our ability to monitor quality and measure outcomes, and understand the psychosocial aspects of care.